Placebo-controlled trial of flosequinan in moderate heart failure. The possible importance of aetiology and method of analysis in the interpretation of the results of heart failure trials

Cowley, 1988, Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects, Br Med J, 297, 169, 10.1136/bmj.297.6642.169 Elborn, 1989, Effect of flosequinan on exercise capacity and symptoms in severe heart failure, Br Heart J, 61, 331, 10.1136/hrt.61.4.331 Cowley, 1991, Exercise tolerance in patients with heart failure:-how should it be measured?, Eur Heart J, 12, 50, 10.1093/oxfordjournals.eurheartj.a059824 Lipkin, 1986, Six minute walk test for assessing exercise capacity in patients with chronic heart failure, Br Med J, 292, 653, 10.1136/bmj.292.6521.653 1988, Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure, J Am Med Assoc, 259, 539, 10.1001/jama.1988.03720040031022 Giles, 1989, Short- and long-acting angiotensin converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure, J Am Coll Cardiol, 13, 1240, 10.1016/0735-1097(89)90294-5 Borg, 1970, Perceived exertion as an indicator of somatic stress, Scand J Rehab Med, 2, 92 Fleming, 1984, Designs for group sequential tests, Controlled Clin Trials, 5, 348, 10.1016/S0197-2456(84)80014-8 Armitage, 1987, Statistical methods in medical research, 282 Cowley, 1986, Symptomatic assessment of patients with heart failure: double blind comparison of increasing doses of diuretics and captopril in moderate heart failure, Lancet, ii, 770, 10.1016/S0140-6736(86)90298-9 Cleland, 1987, Mortality in heart failure: clinical variables of prognostic value, Br Heart J, 58, 572, 10.1136/hrt.58.6.572 Franciosa, 1983, Survival in men with severe chronic left ventricular failure due to either coronary artery disease or idiopathic dilated cardiomyopathy, Am J Cardiol, 51, 831, 10.1016/S0002-9149(83)80141-6